Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 115-120

  Fujimoto, Jiro ^a   Ichigo, Satoshi ^a   Sakaguchi, Hideki ^a   Hirose, Reiko ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial cancer; Neovascularization; PD ECGF

Indexed keywords

MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYOMETRIUM; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEIOMYOMA; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE;

EID: 0032516667     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00129-3     Document Type: Article

References (35)

1. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
2. Srivastava A., Laidler P., Davies R.P., Horgan K., Hughes L. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am. J. Pathol. 133:1988;419-423.
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-7.
4. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., Angeletti G.A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
5. Wakui S., Furusato M., Itoh T., Sasaki H., Akiyama A., Kinoshita I., Asano K., Tokuda T., Aizawa S., Ushigome S. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol. 168:1992;257-262.
6. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143:1993;401-409.
7. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature. 288:1980;551-556.
8. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W., Heldin C.-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
9. Furukawa T., Yoshimura A., Sumizawa T., Haraguchi M., Akiyama S. Angiogenic factor. Nature. 356:1992;668.
10. Sumizawa T., Furukawa T., Haraguchi M., Yoshimura A., Takeyasu A., Ishizawa M., Yamada Y., Akiyama S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. 114:1993;9-14.
11. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S. Angiogenic activity of enzymes. Nature. 368:1994;198.
12. Miyadera K., Sumizawa T., Haraguchi M., Yoshida H., Konstanty W., Yamada Y., Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 55:1995;1687-1690.
13. Finnis C., Dodsworth N., Pollitt C.E., Carr G., Sleep D. Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur. J. Biochem. 212:1993;201-210.
14. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K., Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocyte, reticulocytes and tumors. Biochim. Biophys. Acta. 1034:1990;107-113.
15. Fox S.B., Moghaddam A., Westwood M., Turley H., Bicknell R., Gatter K.C., Harris A.L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol. 176:1995;183-190.
16. Osuga Y., Toyoshima H., Mitsuhashi N., Taketani Y. The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period. Hum. Reprod. 10:1995;989-993.
17. J. Fujimoto, S. Ichigo, H. Sakaguchi, R. Hirose, T. Tamaya, Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrium during the menstrual cycle, Hum. Reprod. (1998), in press.
18. Moghaddam A., Zhang H.T., Fan T.P., Hu D.E., Lees V.C., Turley H., Fox S.B., Gratter K.C., Harris A.L., Bicknell R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA. 92:1995;998-1002.
19. Hata K., Hata T., Iida K., Miyazaki K. Expression of thymidine phosphorylase in uterine sarcoma and uterine leiomyoma: association with microvessel density and Doppler blood flow analysis. Ultrasound Obstet. Gynecol. 10:1997;54-58.
20. FIGO News. Int. J. Gynecol. Obstet. 28:1989;189-193.
21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;315-323.
22. Nishida M., Hino A., Mori K., Matsumoto T., Yoshikubo T., Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull. 19:1996;1407-1411.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
24. Hagiwara K., Stenman G., Honda H., Sahlin P., Andersson A., Miyazono K., Heldin C.-H., Ishikawa F., Takaku F. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol. Cell. Biol. 11:1991;2125-2132.
25. Arcari P., Martinelli R., Salvatore F. The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12:1984;9179-9189.
26. Denekamp J. Vascular as a target for tumor therapy. Prog. Appl. Microcirc. 4:1984;28-38.
27. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A.L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.
28. Morales D.E., Mc Gowan K.A., Grant D.S., Maheshwari S., Bhartiya D., Cid M.C., Kleinman H.K., Schnaper H.M. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 91:1995;755-763.
29. Fujimoto J., Hori M., Ichigo S., Tamaya T. Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle. Gynecol. Endocrinol. 10:1996;193-197.
30. Fujimoto J., Hori M., Ichigo S., Hirose R., Tamaya T. Antiestrogenic compounds inhibit estrogen-induced expression of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. Gen. Pharmacol. 28:1997;215-219.
31. Garrido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial cell growth factor gene expression in ovarian bovine granulosa cells. Growth Factor. 8:1993;109-117.
32. Fujimoto J., Hori M., Ichigo S., Tamaya T. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Invasion Metastasis. 15:1995;203-210.
33. Zang L., Mackenzie I.Z., Rees M.C., Bicknell R. Regulation of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology. 138:1997;4921-4930.
34. Folkman J., Ingber D.E. Angiostatic steroids. Ann. Surg. 206:1987;374-383.
35. Fujimoto J., Hosoda S., Fujita H., Okada H. Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion Metastasis. 9:1989;269-277.